ANL
Price
$1.44
Change
-$0.03 (-2.04%)
Updated
Jul 25 closing price
Capitalization
53.14M
11 days until earnings call
HRGN
Price
$1.43
Change
+$0.01 (+0.70%)
Updated
Jul 25 closing price
Capitalization
22.76M
24 days until earnings call
Interact to see
Advertisement

ANL vs HRGN

Header iconANL vs HRGN Comparison
Open Charts ANL vs HRGNBanner chart's image
Adlai Nortye
Price$1.44
Change-$0.03 (-2.04%)
Volume$6.95K
Capitalization53.14M
Harvard Apparatus Regenerative Technology
Price$1.43
Change+$0.01 (+0.70%)
Volume$1.4K
Capitalization22.76M
ANL vs HRGN Comparison Chart in %
Loading...
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. HRGN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a StrongBuy and HRGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ANL: $1.44 vs. HRGN: $1.43)
Brand notoriety: ANL and HRGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 67% vs. HRGN: 32%
Market capitalization -- ANL: $53.14M vs. HRGN: $22.76M
ANL [@Biotechnology] is valued at $53.14M. HRGN’s [@Biotechnology] market capitalization is $22.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 1 FA rating(s) are green whileHRGN’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 1 green, 4 red.
  • HRGN’s FA Score: 0 green, 5 red.
According to our system of comparison, ANL is a better buy in the long-term than HRGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 3 TA indicator(s) are bullish while HRGN’s TA Score has 3 bullish TA indicator(s).

  • ANL’s TA Score: 3 bullish, 2 bearish.
  • HRGN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ANL is a better buy in the short-term than HRGN.

Price Growth

ANL (@Biotechnology) experienced а -4.00% price change this week, while HRGN (@Biotechnology) price change was +5.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ANL is expected to report earnings on Aug 07, 2025.

HRGN is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANL($53.1M) has a higher market cap than HRGN($22.8M). ANL YTD gains are higher at: -46.373 vs. HRGN (-52.013). HRGN has higher annual earnings (EBITDA): -7.17M vs. ANL (-49.89M). ANL has more cash in the bank: 98M vs. HRGN (1.73M). HRGN has less debt than ANL: HRGN (272K) vs ANL (39.5M). ANL has higher revenues than HRGN: ANL (5M) vs HRGN (418K).
ANLHRGNANL / HRGN
Capitalization53.1M22.8M233%
EBITDA-49.89M-7.17M696%
Gain YTD-46.373-52.01389%
P/E RatioN/AN/A-
Revenue5M418K1,196%
Total Cash98M1.73M5,671%
Total Debt39.5M272K14,522%
FUNDAMENTALS RATINGS
HRGN: Fundamental Ratings
HRGN
OUTLOOK RATING
1..100
92
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANLHRGN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMPGY5.50N/A
N/A
Navios Maritime Holdings, Inc.
SRRE0.19N/A
N/A
Sunrise Real Estate Group, Inc.
OLVI1.05-0.01
-0.94%
Oliveda International, Inc.
BRCHF0.16N/A
-1.82%
Brainchip Holdings Ltd.
AIIXY37.00-2.72
-6.85%
Aixtron SE

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and FGHQF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and FGHQF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
-2.04%
FGHQF - ANL
25%
Poorly correlated
N/A
JAZZ - ANL
22%
Poorly correlated
+0.19%
NVCT - ANL
21%
Poorly correlated
+0.65%
VCEL - ANL
21%
Poorly correlated
+1.01%
MDXG - ANL
21%
Poorly correlated
-1.17%
More

HRGN and

Correlation & Price change

A.I.dvisor tells us that HRGN and FTRE have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HRGN and FTRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRGN
1D Price
Change %
HRGN100%
+0.70%
FTRE - HRGN
6%
Poorly correlated
+4.45%
APLM - HRGN
3%
Poorly correlated
+1.30%
GENFF - HRGN
2%
Poorly correlated
N/A
ANL - HRGN
2%
Poorly correlated
-2.04%
CLDI - HRGN
2%
Poorly correlated
-5.43%
More